| dc.date.accessioned | 2020-04-22T11:39:28Z | |
| dc.date.available | 2020-04-22T11:39:28Z | |
| dc.date.issued | 2020-02-11 | |
| dc.identifier.citation | Health Protection Surveillance Centre, 'Interim infection prevention and control precautions for possible or confirmed 2019 novel Coronavirus (2019 nCov), Middle East Respiratory Syndrome Cornonavirus (MERS-CoV) and Avian Influenza A in healthcare settings : V2, 11/02/2020', [other], Health Protection Surveillance Centre, 2020-02-11 | en |
| dc.description | This guidance has been reviewed in the context of the emergence of a novel Coronavirus in China. Although this is a new virus the experience so far indicates that it spreads in a similar way to other respiratory viruses and that the same steps to limit spread of this virus are likely to be effective. Even without the risk of importation of a novel virus most of these measures are appropriate to protect patients and to protect HCW from infection with the influenza virus and other common respiratory viruses that are circulating. | en |
| dc.language.iso | en | en |
| dc.publisher | Health Protection Surveillance Centre | en |
| dc.rights | Y | en |
| dc.subject | Covid-19 | en |
| dc.subject | Coronavirus | en |
| dc.subject | Infection prevention and control guidance | en |
| dc.title | Interim infection prevention and control precautions for possible or confirmed 2019 novel Coronavirus (2019 nCov), Middle East Respiratory Syndrome Cornonavirus (MERS-CoV) and Avian Influenza A in healthcare settings : V2, 11/02/2020 | en |
| dc.type | other | en |
| dc.type.supercollection | edepositireland | |
| dc.contributor.corporatename | Health Protection Surveillance Centre | en |
| dc.publisher.place | IE | en |
| dc.description.version | Version 2 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.relation.relatedto | TCD Covid-19 Collection | |
| dc.identifier.uri | http://hdl.handle.net/2262/92331 | |
